Abstract:
A system and a method for liquefying natural gas using single mixed refrigerant as refrigeration medium are provided. The system comprises a two-stage mixed refrigerant compressor (1) driven by a motor, two coolers (21, 22), a liquid pump (4), three gas-liquid separators (31, 32, and 6), two throttling devices (51, 52), a plate-fin heat exchanger group (7) and a LNG storage tank (8). The method comprises the following steps: the mixed refrigerant is compressed step by step by using the two-stage mixed refrigerant compressor (1), separated step by step, and gas-phase and liquid phase mixed refrigerant streams obtained from the separation flow into different passages of the heat exchanger group (7) respectively for throttling and heat exchanging. Heat exchange curves of cold fluid and hot fluid in the whole heat exchange process match with each other better by using two-stage heat exchange, thereby flow of the mixed refrigerant is reduced effectively.
Abstract:
An aluminum-based material melting apparatus includes: a furnace; a melt-discharging conduit having an inner portion disposed in the furnace; a driving mechanism mounted on the furnace; a transmission mechanism connected to the driving mechanism; and a scoop member suspended in the furnace and driven by the driving mechanism through the transmission mechanism so as to be movable in the furnace between upper and lower positions and so as to be rotatable relative to the furnace about an axis between scooping and pouring positions.
Abstract:
A resistance-measuring circuit includes a controller for outputting a PWM signal and further for adjusting the duty cycle of the PWM signal, and a sampling circuit for processing the PWM signal and transmitting the processed PWM signal to the sensor. The sampling circuit samples the signal outputted from the sensor to generate a sampled signal with the voltage thereof changing according to any change in the duty cycle of the PWM signal, and further transmits the sampled signal to the controller. The controller obtains the real-time duty cycle of the PWM signal when the voltage of the sampled signal reaches a threshold voltage, and further calculates the exact resistance of the sensor according to the obtained real-time duty cycle of the PWM signal and the threshold voltage. An electronic device with the resistance-measuring circuit is also provided.
Abstract:
A scooter having a rockable platform upon which the rider stands with both feet. The platform is attached by a chain to one-way sprocket wheels mounted to the scooter. rear wheel rotating the rear wheel to propel the scooter in a forward direction as the front end of the platform moves and as the rear end portion of the platform moves down. The scooter has a position to allow the user to place one foot on the ground and one foot on the platform to propel the same.
Abstract:
Compounds of Formula (I), wherein n is 1 or 2, and R1, R2, R3, R4, R5, R6, R7, and R8 are as defined herein, their preparation, pharmaceutical compositions, and methods of use are disclosed.
Abstract:
Compressors are provided which include a motor having a drive shaft; a compression chamber, having an inlet and an outlet; a diaphragm, disposed within the compression chamber such that when the diaphragm is deflected back and forth between a first position and a second position air is drawn in through the inlet and forced out through the outlet; a crankshaft, operatively connected to the drive shaft; a shuttle, configured to be displaced transversely by rotational movement of the crankshaft, and positioned to deflect the diaphragm by its transverse movement; and a guide configured to inhibit non-transverse motion of the shuttle. In some implementations, the compressor occupies a total volume of less than about 15 cubic inches.
Abstract:
The present invention provided a novel human goose-type lysozyme (LYG2) and the polynucleotide encoding the LYG2. The invention also provided the corresponding expression vectors, host cells, antibodies, agonists and antagonists. The invention also provided the method for diagnosis, treatment and prevention of the diseases relative to LYG2 expression.